Delphi Management Partners VIII »

Karyopharm Therapeutics shares owned by Delphi Management Partners VIII

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Delphi Management Partners VIII from 13F filings

Historical chart of Delphi Management Partners VIII investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Delphi Management Partners VIII consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Delphi Management Partners VIII

Quarter filed Position value Share count Share price at filing
2021-09-30 $13M 2.3M 5.82
2021-06-30 $23M 2.3M 10.32
2021-03-31 $24M 2.3M 10.52
2020-12-31 $35M 2.3M 15.48
2019-12-31 $43M 2.3M 19.17

More positions owned by Delphi Management Partners VIII

Tandem Diabetes Common Stock (TNDM)
Karyopharm Therapeutics Common Stock (KPTI)
Calithera Biosciences Common Stock
Mereo BioPharma Group Ads (MREO)

View all positions for Delphi Management Partners VIII

Top funds holding Karyopharm Therapeutics

Vanguard Group
Avidity Partners Management
Palo Alto Investors
Citadel Advisors
GSA Capital Partners
Marshall Wace
Bnp Paribas Arbitrage, Snc
Millennium Management
CAM Group Holding A/S
Deutsche Bank Aktiengesellschaft
Goldman Sachs Group
Jpmorgan Chase & Co
AlphaCentric Advisors
Tejara Capital
Barclays

View all funds holding Karyopharm Therapeutics